Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlonso Padilla, Julio-
dc.contributor.authorCortés Serra, Núria-
dc.contributor.authorPinazo, María Jesús-
dc.contributor.authorBottazzi, María Elena-
dc.contributor.authorAbril, Marcelo-
dc.contributor.authorBarreira, Fabiana-
dc.contributor.authorSosa-Estani, Sergio-
dc.contributor.authorHotez, Peter Jay-
dc.contributor.authorGascón i Brustenga, Joaquim-
dc.description.abstractDear Editor, We appreciate the comments on our recent review article about strategies to enhance access to diagnosis and treatment for Chagas disease patients [1,2]. We also appreciate the opportunity to respond to them, and expand the discussion on this crucial topic given that it is estimated that no more than 1% of the infected population by Trypanosoma cruzi (of ~7 million people) ultimately get access to treatment [3]. The letter comments mainly refer to two of the sections of the review article: diagnostics to detect the infection (section 2), and treatment opportunities and possibilities (section 7).-
dc.format.extent4 p.-
dc.publisherTaylor & Francis-
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofExpert Review of Anti-infective Therapy, 2019-
dc.rights(c) Informa UK Limited, 2019-
dc.subject.classificationMalaltia de Chagas-
dc.subject.classificationAmèrica Llatina-
dc.subject.otherChagas' disease-
dc.subject.otherLatin America-
dc.titleResponse to `letter to the editor: 'Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America'´-
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Alonso-PadillaJ_Expert_Rev_Anti_Infect_Ther_2019.pdf700.3 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.